MariMed Inc. (MRMD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts MRMD Hot Sheet
Join SI Premium – FREE
MariMed Inc. (OTC: MRMD) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $41.92 million versus the consensus estimate of $40.95 million.
For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
- HSBC Upgrades Sembcorp Industries (SCI:SP) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
